Denali Therapeutics Inc (DNLI) — Long-term Investment Intensity
Denali Therapeutics Inc (DNLI) has a Long-term Investment Intensity of 2.3% as of September 2025. Long-term investments of $24.70 Million represent 2.3% of total assets of $1.06 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See DNLI net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Denali Therapeutics Inc Long-term Investment Intensity (2016–2024)
This chart shows how Denali Therapeutics Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2016 to 2024. As of September 2025, the intensity stands at 2.3%, reflecting long-term investments of $24.70 Million against total assets of $1.06 Billion USD. Also explore Denali Therapeutics Inc total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Denali Therapeutics Inc (2016–2024)
The table below presents the year-by-year Long-term Investment Intensity for Denali Therapeutics Inc from 2016 to 2024, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Denali Therapeutics Inc market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 26.2% | $359.37 Million | $1.37 Billion | ▼ -4.1 pp |
| 2021 | 30.3% | $425.45 Million | $1.40 Billion | ▲ +28.3 pp |
| 2020 | 2.0% | $32.70 Million | $1.60 Billion | ▼ -5.2 pp |
| 2019 | 7.2% | $39.89 Million | $553.23 Million | ▼ -15.1 pp |
| 2018 | 22.3% | $147.88 Million | $661.98 Million | ▲ +9.8 pp |
| 2017 | 12.6% | $61.25 Million | $486.72 Million | ▼ -14.4 pp |
| 2016 | 27.0% | $73.08 Million | $271.07 Million | — |